CGTX Logo

Cognition Therapeutics, Inc. (CGTX) 

NASDAQ
Market Cap
$68.1M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
367 of 809
Rank in Industry
223 of 445

Largest Insider Buys in Sector

CGTX Stock Price History Chart

CGTX Stock Performance

About Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinical trial to treat early-stage Alzheimer's disease; in Phase II clinical trial for the treatment of dementia with Lewy bodies (DLB); and in preclinical trial to treat dry age-related macular degeneration (AMD). The company is also developing CT2168 for the treatment of synucleinopathies, which include DLB and Parkinson's disease; and CT2074 to treat dry AMD. Cognition Therapeutics, Inc. was incorporated in 2007 and is headquartered in Purchase, New York.

Insider Activity of Cognition Therapeutics, Inc.

Over the last 12 months, insiders at Cognition Therapeutics, Inc. have bought $9,975 and sold $0 worth of Cognition Therapeutics, Inc. stock.

On average, over the past 5 years, insiders at Cognition Therapeutics, Inc. have bought $3.75M and sold $4,818 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Ricciardi Lisa (CEO & President) — $19,950.

The last purchase of 5,700 shares for transaction amount of $9,975 was made by Ricciardi Lisa (CEO & President) on 2024‑03‑14.

List of Insider Buy and Sell Transactions, Cognition Therapeutics, Inc.

2024-03-14PurchaseRicciardi LisaCEO & President
5,700
0.0172%
$1.75$9,975+8.94%
2022-11-29PurchaseRICHSTONE ELLEN Bdirector
10,000
0.0453%
$2.65$26,550-29.84%
2022-11-28PurchaseKreis Leslie W.director
16,064
0.0706%
$2.65$42,565-31.76%
2022-11-28PurchaseFletcher Aaron G.L.director
16,064
0.0706%
$2.65$42,565-31.76%
2022-11-16PurchaseKreis Leslie W.director
71,000
0.3069%
$1.40$99,400+27.37%
2022-11-16PurchaseFletcher Aaron G.L.director
71,000
0.3069%
$1.40$99,400+27.37%
2022-11-15PurchaseKreis Leslie W.director
1.5M
5.2511%
$1.20$1.8M+20.34%
2022-11-15PurchaseFletcher Aaron G.L.director
1.5M
5.2511%
$1.20$1.8M+20.34%
2022-11-15PurchaseWallace Peggydirector
12,500
0.0438%
$1.20$15,000+20.34%
2022-11-15PurchaseRicciardi LisaCEO & President
12,000
0.0455%
$1.30$15,600+20.34%
2021-10-13SaleOgden CAP Associates, LLC10 percent owner
74.05
0.0014%
$12.00$889-76.39%
2021-10-13SaleGolden Seeds Cognition Therapeutics LLC10 percent owner
33.09
0.0006%
$12.00$397-76.39%
2021-10-13SaleBreedlove Mark H.director
23.48
0.0004%
$12.00$282-76.39%
2021-10-13SaleFletcher Aaron G.L.director
180.56
0.0034%
$12.00$2,167-76.39%
2021-10-13SaleBIOS Memory SPV I, LP10 percent owner
90.28
0.0017%
$12.00$1,083-76.39%
2021-10-13PurchaseFletcher Aaron G.L.director
380,000
7.2005%
$12.00$4.56M-76.39%
2021-10-13PurchaseBIOS Memory SPV I, LP10 percent owner
190,000
3.6003%
$12.00$2.28M-76.39%
2021-10-13PurchaseRicciardi LisaCEO & President
25,000
0.4737%
$12.00$300,000-76.39%
2021-10-13PurchaseO'Brien James MichaelChief Financial Officer
10,000
0.1895%
$12.00$120,000-76.39%
2021-10-13PurchaseWallace Peggydirector
3,000
0.0568%
$12.00$36,000-76.39%

Insider Historical Profitability

<0.0001%
Ricciardi LisaCEO & President
291345
0.0763%
$1.7030<0.0001%
Ogden CAP Associates, LLC10 percent owner
2210377
6.8812%
$1.7001
Golden Seeds Cognition Therapeutics LLC10 percent owner
2177985
6.7804%
$1.7001
Kreis Leslie W.director
2021906
6.2945%
$1.7030+5.32%
Fletcher Aaron G.L.director
2021906
6.2945%
$1.7041<0.0001%
BIOS Memory SPV I, LP10 percent owner
899905
2.8015%
$1.7011<0.0001%
Breedlove Mark H.director
404439
1.2591%
$1.7001
Wallace Peggydirector
37961
0.1182%
$1.7020<0.0001%
RICHSTONE ELLEN Bdirector
10000
0.0311%
$1.7010<0.0001%
O'Brien James MichaelChief Financial Officer
5000
0.0156%
$1.7010<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Aigh Capital Management Llc$3.45M4.741.9M-6.94%-$257,675.612.05
The Vanguard Group$1.68M2.3921,680+27.73%+$364,229.41<0.0001
Awm Investment Company Inc$1.18M1.62650,000New+$1.18M0.18
Alyeska Investment Group L P$910,000.001.25500,000New+$910,000.000.01
Timelo Investment Management Inc.$874,839.001.2480,681New+$874,839.001.6
Corsair Capital Management LP$518,700.000.71285,000New+$518,700.000.15
Hohimer Wealth Management Llc$409,500.000.56225,000New+$409,500.000.1
Carlson Capital, L.P.$389,471.000.53213,995-10.09%-$43,689.110.04
American Financial Group$373,000.000.51205,0000%+$00.16
Kestra Advisory Services LLC$362,970.000.5199,434-9.11%-$36,400.01<0.01
Geode Capital Management$337,140.000.46185,196+5.95%+$18,929.04<0.0001
Cm Management Llc$318,500.000.44175,000New+$318,500.000.02
Sigma Planning Corp$290,181.000.4159,440+458.46%+$238,219.960.01
Renaissance Technologies$283,000.000.39155,700+1,197.5%+$261,188.83<0.0001
Bridgeway Capital Management$139,594.000.1976,700-15.9%-$26,390.00<0.01
Mercer Global Advisors Inc Adv$131,000.000.1871,901-45.09%-$107,586.13<0.0001
BlackRock$101,592.000.1455,820+0.38%+$384.02<0.0001
Texas Capital Bank Wealth Management Services Inc$100,819.000.1455,3950%+$00.01
FCA Corp$93,677.000.1351,4710%+$00.03
State Street$92,365.000.1350,7500%+$0<0.0001
Circle Wealth Management, LLC$88,893.000.1248,842New+$88,893.00<0.01
Northern Trust$86,423.000.1247,485+54.56%+$30,508.77<0.0001
Levin Capital Strategies$54,600.000.0830,000New+$54,600.000.01
Tocqueville Asset Management$47,320.000.0726,000New+$47,320.00<0.01
NORTHEAST FINANCIAL CONSULTANTS, INC$44,590.000.0624,5000%+$0<0.01
Bangor Savings Bank$43,715.000.0624,0190%+$0<0.01
Hightower Advisors$41,000.000.0622,962-30.34%-$17,855.59<0.0001
Baird Financial Group Inc$40,755.000.0622,3930%+$0<0.0001
Gratus Capital$33,532.000.0518,424New+$33,532.00<0.01
Acadian Asset Management$23,000.000.0312,691New+$23,000.00<0.0001
Charles Schwab$21,776.000.0311,9650%+$0<0.0001
Smith Anglin Financial Llc$21,840.000.0312,0000%+$0<0.01
Raymond James Associates$18,200.000.0310,000New+$18,200.00<0.0001
Tower Research Capital$11,681.000.026,418+31.87%+$2,822.88<0.0001
Northwestern Mutual Wealth Management Co$10,678.000.025,8670%+$0<0.0001
Bank of America$9,100.000.015,000-0.28%-$25.48<0.0001
Morgan Stanley$5,460.000.013,000-86.28%-$34,341.58<0.0001
Bray Capital Advisors$4,095.000.012,2500%+$0<0.01
Sandy Spring Bank$3,640.000.012,000New+$3,640.00<0.0001
Qube Research & Technologies$3,860.000.012,121New+$3,860.00<0.0001
Advisor Group Holdings Inc$2,120.00<0.011,165New+$2,120.00<0.0001
Royal Bank of Canada$0<0.014-97.99%-$0<0.0001
Fidelity Investments$2.00<0.0110%+$0<0.0001
JPMorgan Chase$127.00<0.0170+100%+$63.50<0.0001
Wells Fargo$266.00<0.01146+7.35%+$18.22<0.0001